Presentation Synopsis
This educational presentation by the Opioid Remediation Collaborative (ORCNM) explores the scientific evidence supporting addiction as a chronic brain disease and the role of medications in treating Opioid Use Disorder (OUD). It is designed to shift perspectives, reduce stigma, and provide a foundation for understanding evidence-based treatment approaches.
The presentation reviews the neurobiology of addiction, including changes in the brain’s reward system, risk factors for developing substance use disorders, and the natural progression of addiction. It also highlights the effectiveness of medications for opioid use disorder (MOUD), emphasizing their role in stabilizing patients, reducing mortality, and supporting long-term recovery.
Learning Objectives
-
Understand addiction as a chronic brain disease rather than a moral failing
-
Describe the neurobiological mechanisms of addiction, including the brain’s reward pathway and dopamine signaling
-
Identify key risk factors for developing substance use disorders, including genetic, environmental, and psychological influences
-
Understand how chronic drug use alters brain structure and function over time
-
Recognize the natural history of addiction, including tolerance, dependence, withdrawal, and relapse
-
Identify the role and effectiveness of medications for opioid use disorder, including methadone, buprenorphine, and naltrexone
-
Understand how MOUD supports stabilization, reduces overdose risk, and improves treatment retention
-
Address common misconceptions and stigma associated with medication-assisted treatment
-
Recognize the importance of comprehensive, long-term, and patient-centered approaches to recovery